NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?
- PMID: 30120070
- DOI: 10.1016/S1473-3099(18)30430-4
NmCV-5 meningococcal vaccine: Neisseria meningitidis' nemesis?
Comment on
-
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14. Lancet Infect Dis. 2018. PMID: 30120069 Clinical Trial.
Similar articles
-
Safety and immunogenicity of a pentavalent meningococcal conjugate vaccine containing serogroups A, C, Y, W, and X in healthy adults: a phase 1, single-centre, double-blind, randomised, controlled study.Lancet Infect Dis. 2018 Oct;18(10):1088-1096. doi: 10.1016/S1473-3099(18)30400-6. Epub 2018 Aug 14. Lancet Infect Dis. 2018. PMID: 30120069 Clinical Trial.
-
Meningococcal Serogroup ACWYX Conjugate Vaccine in Malian Toddlers.N Engl J Med. 2021 Jun 3;384(22):2115-2123. doi: 10.1056/NEJMoa2013615. N Engl J Med. 2021. PMID: 34077644 Clinical Trial.
-
Use of expanded Neisseria meningitidis serogroup B panels with the serum bactericidal antibody assay for the evaluation of meningococcal B vaccine effectiveness.Expert Rev Vaccines. 2023 Jan-Dec;22(1):738-748. doi: 10.1080/14760584.2023.2244596. Expert Rev Vaccines. 2023. PMID: 37622470 Review.
-
[Meningococcal vaccines: from polysaccharide to conjugate vaccines].Arch Pediatr. 2012 Sep;19 Suppl 2:S61-4. doi: 10.1016/S0929-693X(12)71275-7. Arch Pediatr. 2012. PMID: 22883368 French.
-
Serogroup B meningococcal vaccines-an unfinished story.Lancet Infect Dis. 2010 Feb;10(2):112-24. doi: 10.1016/S1473-3099(09)70324-X. Lancet Infect Dis. 2010. PMID: 20113980 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical